USFDA gives final approval for Chlorthalidone Tablets USP

Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.

190
USFDA Drug product Approval
USFDA Approval

Last Updated on December 24, 2023 by The Health Master

The US Food and Drug Administration (USFDA) has given final approval to Alembic Pharma’s Abbreviated New Drug Application (ANDA) for Chlorthalidone Tablets USP, 25 mg and 50 mg.

The approved ANDA is therapeutically equivalent to the reference-listed drug (RLD) product, Hygroton Tablets, 25 mg, and 50 mg, by Sanofi.

Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other anti-hypertensive drugs in the more severe forms of hypertension.

Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.

Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure, the statement further said.

The statement concluded that Chlorthalidone Tablets USP, 25 mg and 50 mg, have an estimated market size of $37 million for the twelve months ending June 2022, according to IQVIA.

USFDA gives tentative nod for Dasatinib tablets

USFDA gives approval for this Contraceptive

USFDA gives nod for Formoterol Fumarate inhalation solution

USFDA gives nod for generic Carbamazepine tablets

USFDA gives approval for this BP monitor device

USFDA gives nod for generic Naproxen Sodium Softgel Capsules

USFDA issues Form 483 with one observation to Aurobindo Pharma subsidiary’s plant

USFDA gives tentative nod for Dasatinib tablets

Pharma company fined for dumping medical waste in open

USFDA issues Form 483 with 6 observations to Cipla

Penalty provision for Blood Banks / Centres not updating stock in time

Govt invites eligible Medical Devices Firms Category B of PLI scheme

Drug Rules 1945 amended to allow parallel submission of manufacturing & marketing approvals

This Air is an essential element for the Tablet Coating Process

NPPA fixes Retail Prices of 45 drug formulations

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news